刘格，助理研究员，本科毕业于东北师范大学生物技术专业，硕士就读于中科院海洋研究所海洋药物专业，博士期间就读中科院海洋所海洋生物专业，主要从事海洋来源的抗肿瘤药物的筛选及作用机制研究。目前研究方向为深海微生物新型代谢途径的发现及抗肿瘤活性物质的发掘利用。

  已发表的第一作者论文：

(1)       Liu Ge; Kuang Shan; Cao Ruobing; Wang Ju; Peng Quancai; Sun Chaomin*. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway. FASEB Journal , 2019,33(9).

(2)       Liu Ge; Wang Kai; Kuang Shan; Cao Ruobing; Bao Li; Liu Rui; Liu Hongwei*. Sun Chaomin* The natural compound GL22, isolated from Ganoderma mushrooms, suppresses tumor growth by altering lipid metabolism and triggering cell death. Cell Death & Disease, 2018, 9(6):689.

(3)       Liu Ge; Kuang Shan; Wu Shimei; Jin Weihua*; Sun Chaomin*. A novel polysaccharide from Sargassum integerrimum induces apoptosis in A549 cells and prevents angiogensis in vitro and in vivo. Scientific Reports, 2016, 6(26722).

(4)       Liu Ge; Liu Ming*; Wei Jianteng; Huang Haijun; Zhang Yuyan; Zhao Jin; Xiao Lin; Wu Ning; Zheng Lanhong; Lin Xiukun*. CS5931, a novel polypeptide in Ciona savignyi, represses angiogenesis via inhibiting vascular endothelial growth factor (VEGF) and matrix Metalloproteinases (MMPs). Marine Drugs, 2014, 12(3), 1530-1544.

(5)       Qi Xin^#; Liu Ge^#; Qiu Lin; Lin Xiukun; Liu Ming*. Marine bromophenol bis (2,3- dibromo-4,5-dihydroxybenzyl) ether, represses angiogenesis in HUVEC cells and in zebrafish embryos via inhibiting the VEGF signal systems. Biomedicine & Pharmacotherapy,2015,75:58-66.